Libman-Sacks endocarditis in the antiphospholipid syndrome: Immunopathologic findings in deformed heart valves

Lupus

Volumn 5, Issue 3, 1996, Pages 196-205

  Ziporen, L ^a   Goldberg, I ^a   Arad, M ^b   Hojnik, M ^a   Ordi Ros, J ^c   Afek, A ^a   Blank, M ^a   Sandbank, Y ^b   Vilardell Tarres, M ^c   De Torres, I ^c   Weinberger, A ^b   Asherson, R A ^d   Kopolovic, Y ^a   Shoenfeld, Y ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c Vall d'Hebron   (Spain)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Antibodies; Anticardiolipin; Antiphospholipid syndrome; Heart valves; Libman Sacks endocarditis; Systemic lupus erythematosus

Indexed keywords

CARDIOLIPIN; COMPLEMENT; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PHOSPHOLIPID ANTIBODY; SERUM ALBUMIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCARDITIS; FEMALE; HEART VALVE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOPATHOLOGY; IMMUNOPEROXIDASE STAINING; LIBMAN SACKS ENDOCARDITIS; MALE; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; VALVULAR HEART DISEASE;

EID: 8944227500     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500306     Document Type: Article

References (50)

1. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 1924; 33: 701-737.
2. Gross L. The cardiac lesion in Libman-Sacks disease with a consideration of its relationship to acute diffuse lupus erythematosus. Am J Pathol 1940; 16: 375-408.
3. Klinkhoff AV et al. M-mode and two-dimensional echocardiographic abnormalities in systemic lupus erythematosus. JAMA 1985; 253: 3273-3277.
4. Doherty NE et al. Echocardiographic findings in systemic lupus erythematosus. Am J Cardiol 1988; 61: 1144.
5. Galve E et al. Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med 1988; 319: 817-823.
6. Nihoyannopoulos P et al. Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation 1990; 82: 369-375.
7. Cervera R et al. Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 1992; 51: 156-159.
8. Guinta A et al. Spectrum of cardiac involvement in systemic lupus erythematosus: echocardiographic, echo-doppler observations and immunological investigations. Acta Cardiol 1993; 48: 183-197.
9. Straaton KV et al. Clinically significant valvular heart disease in systemic lupus erythematosus. Am J Med 1988; 85: 645-650.
10. Chartash EK et al. Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Med 1989; 86: 407-412.
11. Khamashta MA et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990; 335: 1541-1544.
12. Crozier IG et al. Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am J Cardiol 1990; 65: 1145-1148.
13. Bulkley BH, Roberts WC: The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: a study of 36 necropsy patients. Am J Med 1975; 58: 243-264.
14. Shearn MA: The heart in systemic lupus erythematosus: a review. Am Heart J 1959; 58: 452-466.
15. Durack DT: Experimental bacterial endocarditis: 4. Structure and evolution of very early lesions. J Pathol 1975; 115: 81-89.
16. Asherson RA, Hughes GRV: The expanding spectrum of Libman Sacks endocarditis: the role of anti-phospholipid antibodies. Clin Exp Rheum 1989; 7: 225-228.
17. Shapiro RF et al. Immunopathogenesis of Libman-Sacks endocarditis. Ann Rheum Dis 1977; 36: 508-516.
18. Gomez P et al. Association between cardiac abnormalities and raised anticardiolipin antibodies in systemic lupus erythematosus. Postgrad Med J 1988; 64: 723.
19. Leung WH et al. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 1990; 89: 411-419.
20. Metz D et al. Prevalence of valvular involvement in systemic lupus erythematosus and association with antiphospholipid syndrome: a matched echocardiographic study. Cardiology 1994; 85: 129-136.
21. Barbut D et al. Anticardiolipin antibody and stroke: possible relation of valvular heart disease and embolic events. Cardiology 1991; 79: 99-109.
22. Asherson RA, Cervera R: The antiphospholipid syndrome: a syndrome in evolution. Ann Rheum Dis 1992; 51: 147-150.
23. Brenner B et al. Cardiac involvement in patients with primary antiphospholipid syndrome. J Am Coll Cardiol 1991; 18: 931-936.
24. Cervera R et al. High prevalence of significant heart valve lesions in patients with the 'primary' antiphospholipid syndrome. Lupus 1991; 1: 43-47.
25. Galve E et al. Valvular heart disease in the primary antiphospholipid syndrome. Ann Intern Med 1992; 116: 293-298.
26. Harris EN: Annotation. Antiphospholipid antibodies. Br J Haematol 1990; 74: 1-9.
27. Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum 1982; 25: 1271-1277.
28. Sutjita M et al. A common anti-cardiolipin antibody idiotype in autoimmune disease: identification using a mouse monoclonal antibody directed against a naturally-occurring anti-phospholipid antibody. Clin Exp Immunol 1989; 75: 211-216.
29. Sutjita M et al. Polyspecific human and murine antibodies to diphteria and tetanus toxoids and phospholipids. Clin Exp Immunol 1988; 73: 191-197.
30. Bakimer R et al. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest 1992; 89: 1558-1663.
31. Blank M et al. Suppression of experimental systemic lupus erythematosus (SLE) with specific anti-idiotypic antibody-saporin conjugate. Clin Exp Immunol 1994; 98: 434-441.
32. 2-glycoprotein I: analysis of anticardiolipin antibodies in leprosy. Lupus 1994; 3: 515-521.
33. Bidani AK et al. Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 1980; 69: 849-858.
34. Merz H et al. Constant detection of surface and cytoplasmic immunoglobulin heavy and light chain expression in formalin-fixed and paraffin-embedded material. J Pathol 1993; 170: 257-264.
35. D'Alton JG et al. Multiple transient ischemic attacks, lupus anti-coagulant and verrucous endocarditis. Stroke 1985; 16: 512-514.
36. Roldan CA et al. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol 1992; 20: 1127-1134.
37. Gleason CB et al. A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome vs anticardiolipin-negative systemic lupus erythematosus. Am Heart J 1993; 25: 1123-1129.
38. Koike T, Tomioka H, Kumagai A: Antibodies cross-reactive with DNA and cardiolipin in patients with systemic lupus erythematosus. Clin Exp Immunol 1982; 50: 298-302.
39. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4124.
40. 2-glycoprotein I in the absence of phospholipid. J Immunol 1995; 154: 954-960.
41. Brey RL, Coull BM: Antiphospholipid antibodies: origin, specificity and mechanism of action. Stroke 1992; 23: 15-18.
42. Hasselaar P et al. Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets. Thromb Haemostas 1990; 63: 169-173.
43. McGrae KR et al. Detection of endothelial cell reactive immunoglobulin in patients with antiphospholipid antibodies. Br J Haematol 1991; 79: 595-605.
44. Cervera R et al. Antiendothelial cell antibodies in patients with the antiphospholipid syndrome. Autoimmunity 1991; 11: 1-6.
45. Galli M, Bevers EM: Inhibition of phospholipid-dependent coagulation reactions by 'antiphospholipid antibodies': possible modes of action. Lupus 1994; 3: 223-228.
46. Ford SE et al. Thrombotic endocarditis and lupus anticoagulant. Arch Pathol Lab Med 1989; 113: 350-353.
47. Escolar G et al. Plasma from systemic lupus erythematosus patients with antiphospholipid antibodies promotes platelet aggregation. Studies in a perfusion system. Arterloscler Thromb 1992; 12: 196-200.
48. Kornberg A et al. Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. J Immunol 1994; 153: 1328-1332
49. Oosting JD et al. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S: an explanation for their pathogenic mechanism. Blood 1993; 81: 2618-2625.
50. Chorzelski T, Jablonska S, Blaszczyk M: Immunopathologic investigations in lupus erythematosus. J Invest Dermat 1969; 52: 333-337.